These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 6340275)

  • 1. Acute renal toxicity with combined use of amphotericin B and cyclosporine after marrow transplantation.
    Kennedy MS; Deeg HJ; Siegel M; Crowley JJ; Storb R; Thomas ED
    Transplantation; 1983 Mar; 35(3):211-5. PubMed ID: 6340275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minimal risk of chronic renal dysfunction in marrow transplant recipients treated with cyclosporine for 6 months.
    Yee GC; McGuire TR; St Pierre BA; Self SG; Zager RA; Sullivan KM; Deeg HJ
    Bone Marrow Transplant; 1989 Nov; 4(6):691-4. PubMed ID: 2684309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterizing and predicting amphotericin B-associated nephrotoxicity in bone marrow or peripheral blood stem cell transplant recipients.
    Gubbins PO; Penzak SR; Polston S; McConnell SA; Anaissie E
    Pharmacotherapy; 2002 Aug; 22(8):961-71. PubMed ID: 12173799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Profound hypomagnesemia and renal magnesium wasting associated with the use of cyclosporine for marrow transplantation.
    June CH; Thompson CB; Kennedy MS; Nims J; Thomas ED
    Transplantation; 1985 Jun; 39(6):620-4. PubMed ID: 3890292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclosporine-associated renal dysfunction in marrow transplant recipients.
    Yee GC; Kennedy MS; Deeg HJ; Leonard TM; Thomas ED; Storb R
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):196-201. PubMed ID: 3895662
    [No Abstract]   [Full Text] [Related]  

  • 6. Nephrotoxicity of cyclosporine A and amphotericin B-deoxycholate as continuous infusion in allogenic stem cell transplantation.
    Furrer K; Schaffner A; Vavricka SR; Halter J; Imhof A; Schanz U
    Swiss Med Wkly; 2002 Jun; 132(23-24):316-20. PubMed ID: 12362282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic cyclosporine-associated nephrotoxicity in bone marrow transplant patients.
    Dieterle A; Gratwohl A; Nizze H; Huser B; Mihatsch MJ; Thiel G; Tichelli A; Signer E; Nissen C; Speck B
    Transplantation; 1990 Jun; 49(6):1093-100. PubMed ID: 2193442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxicity of amphotericin B plus flucytosine in 194 patients with cryptococcal meningitis.
    Stamm AM; Diasio RB; Dismukes WE; Shadomy S; Cloud GA; Bowles CA; Karam GH; Espinel-Ingroff A
    Am J Med; 1987 Aug; 83(2):236-42. PubMed ID: 3303926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia.
    Storb R; Deeg HJ; Whitehead J; Appelbaum F; Beatty P; Bensinger W; Buckner CD; Clift R; Doney K; Farewell V
    N Engl J Med; 1986 Mar; 314(12):729-35. PubMed ID: 3513012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of amphotericin B lipid complex injection (ABLC) in bone marrow transplant recipients with life-threatening systemic mycoses.
    Wingard JR
    Bone Marrow Transplant; 1997 Feb; 19(4):343-7. PubMed ID: 9051244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence that oral pentoxifylline reverses acute renal dysfunction in bone marrow transplant recipients receiving amphotericin B and cyclosporine. Results of a pilot study.
    Bianco JA; Almgren J; Kern DL; Ballard B; Roark K; Andrews F; Nemunaitis J; Shields T; Singer JW
    Transplantation; 1991 Apr; 51(4):925-7. PubMed ID: 2014558
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of invasive fungal infections with amphotericin B colloidal dispersion in bone marrow transplant recipients.
    Noskin G; Pietrelli L; Gurwith M; Bowden R
    Bone Marrow Transplant; 1999 Apr; 23(7):697-703. PubMed ID: 10218847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Candidiasis in the transplant patient.
    Clift RA
    Am J Med; 1984 Oct; 77(4D):34-8. PubMed ID: 6388324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population pharmacokinetics and renal function-sparing effects of amphotericin B colloidal dispersion in patients receiving bone marrow transplants.
    Amantea MA; Bowden RA; Forrest A; Working PK; Newman MS; Mamelok RD
    Antimicrob Agents Chemother; 1995 Sep; 39(9):2042-7. PubMed ID: 8540713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of low-dose dopamine in preventing amphotericin B nephrotoxicity in bone marrow transplant patients and leukemia patients.
    Camp MJ; Wingard JR; Gilmore CE; Lin LS; Dix SP; Davidson TG; Geller RB
    Antimicrob Agents Chemother; 1998 Dec; 42(12):3103-6. PubMed ID: 9835498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose amphotericin B prophylaxis against invasive Aspergillus infections in allogeneic marrow transplantation.
    Rousey SR; Russler S; Gottlieb M; Ash RC
    Am J Med; 1991 Nov; 91(5):484-92. PubMed ID: 1951410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nephrotoxicity in bone marrow transplant recipients receiving aminoglycoside plus cyclosporine or aminoglycoside alone.
    Chandrasekar PH; Cronin SM
    J Antimicrob Chemother; 1991 Jun; 27(6):845-9. PubMed ID: 1938691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of nephrotoxicity in patients treated with amphotericin B for suspected or proven aspergillosis.
    Wingard JR; Kubilis P; Lee L; Yee G; White M; Walshe L; Bowden R; Anaissie E; Hiemenz J; Lister J
    Clin Infect Dis; 1999 Dec; 29(6):1402-7. PubMed ID: 10585786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of liposomal amphotericin B (AmBisome) in 187 transplant recipients treated with cyclosporin.
    Ringdén O; Andström E; Remberger M; Svahn BM; Tollemar J
    Bone Marrow Transplant; 1994; 14 Suppl 5():S10-4. PubMed ID: 7703925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of nephrotoxicity of high-cumulative dose of liposomal amphotericin B in a pediatric patient who underwent allogeneic bone marrow transplantation.
    Cesaro S; Zignol M; Burlina AB; Tridello G; Visintin G; Messina C
    Pediatr Transplant; 2006 Mar; 10(2):255-8. PubMed ID: 16573618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.